. 24/7 Space News .
$85 Million Awarded For Research On Human Immunity And Biodefense


Washington - Sep 19, 2003
A better understanding of the human immune response to potential agents of bioterror and rapid development of countermeasures such as vaccines and therapies are among the objectives of a new program announced today by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH).

"NIH is dedicated to supporting research that will help in fighting the war on terror," says NIH Director Elias A. Zerhouni, M.D. NIAID has named five Cooperative Centers for Translational Research on Human Immunology and Biodefense. Approximately $85 million over four-and-a-half years will support research at

Baylor Research Institute (Dallas, TX) Dana-Farber Cancer Institute (Boston, MA) Emory University School of Medicine (Atlanta, GA) Stanford University School of Medicine (Stanford, CA) University of Massachusetts Medical School (Worcester, MA)

"A particular emphasis of these cooperative centers will be moving new findings about immune system function out of the lab and into clinical trials," says NIAID Director Anthony S. Fauci, M.D. "The flexibility of the program will allow research projects to be redirected quickly as new information is generated in the lab and the clinic."

Investigators funded through the new program will form a biodefense research network with a focus on the human immune system. It is much more difficult to perform studies of immunity in humans than in animal models.

Human volunteers cannot be deliberately exposed to agents of bioterror to determine the effectiveness of a trial vaccine, for example. Also, differences in human age, sex, race and overall health all influence immune system function.

The absence of necessary technologies is a significant barrier in human immune function research, says Helen Quill, Ph.D., of NIAID's Division of Allergy, Immunology and Transplantation (DAIT).

To overcome this obstacle, researchers at the cooperative centers will, among other measures, develop new ways to get information from single immune cells, so that very small tissue and blood samples can be tested.

Imaging technologies will also be developed to allow non-invasive, real-time views of the body as it reacts to vaccine or infection, Dr. Quill notes. The improved techniques could help researchers determine the immune mechanisms responsible for strong versus weak vaccine responses. The information, in turn, will be useful in developing novel vaccines.

"One of the key features of these new centers will be the high degree of information-sharing by all the members," notes Daniel Rotrosen, M.D., director of DAIT.

"Ultimately, we hope to fully characterize human immune responses to disease-causing organisms and develop therapies that strengthen these responses, whether the organisms are deliberately released or arise naturally in the environment," he says. "The cooperative centers will encourage the kind of synergy needed to meet this goal."

NIAID is a component of the National Institutes of Health (NIH), which is an agency of the Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

Related Links
National Institute of Allergy and Infectious Diseases
SpaceDaily
Search SpaceDaily
Subscribe To SpaceDaily Express



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


Terror Threats Accelerates Need for Detection Systems
Palo Alto - Sep 16, 2003
Governments and individual consumers alike look for detection methods to protect themselves against potential, and increasingly, unconventional terror strikes such as the use of chemical and biological agents. New analysis from Frost & Sulliva, World Chemical and Biological Agent Detection Markets, reveals industry revenues forecasted to total $1.095 billion in 2003 and are projected to reach $1.687 billion by 2009.







  • Say Goodbye To Your Mouse, Keyboard And Phone Number
  • NASA Wants You To Be A Solar System Ambassador
  • Bill to Restore Vision for NASA's Human Spaceflight Program Re-Introduced
  • Lance Bass Named Youth Spokesperson For World Space Week

  • Early Mars Was Frozen: But Habitable
  • Chomping Away On Martian Nano-Nuggets
  • Surveying The Scene - Martian Style
  • The Planet that Won't Go Away

  • ILS To Launch Third HISPASAT Bird
  • ILS To Launch SES Americom Broadband Bird Next Year
  • Rocket Propellant Leak Occurs During Titan 4 Operation
  • Atlas V Launches Rainbow 1 Satellite

  • Orbimage Set To Clears Remaining Hurdle To Exit Bankruptcy
  • Burning Oil Cloud Above Northern Iraq
  • Satellites Sample Hurricane Ingredients To Help Forecasters
  • INSAT Search & Rescue System Helps Save 28 Lives

  • Pluto Mission May Be Early Victim Of Growing Budget Crisis
  • Pluto Mission May Be Early Victim Of Growing Budget Crisis
  • Pluto Mission May Be Early Victim Of Growing Budget Crisis
  • Atlas V Chosen To Launch New Horizons Mission

  • Gamma-Ray Bursts: Are We Safe?
  • Berkeley Payload On Korean Satellite To Be Launched By Russian Sept 26
  • First Supernovae Quickly Seeded Universe With Stuff Of Life
  • MIT-led Team: Dark Gamma-ray Bursts More Flighty Than Shy

  • Lunar Prospecting With Chandra
  • New UK Technology Will Make The First Global X-Ray Map Of The Moon
  • Indian Prime Minister Announces Mission to Moon
  • Europe Looking Forward To Small Smart Lunar Mission

  • Europe Helps China Setup Satellite Navigation Centre
  • VR Could Speed Up New Car Development
  • Satellites Tracking Could Greatly Facilitate Pay As You Go Driving
  • GPS Saved Trapped Miners

  • The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement